Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2391-2396
Published online before print October 7, 2004, doi: 10.1161/01.ATV.0000147029.63303.28
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/12/2391    most recent
01.ATV.0000147029.63303.28v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, J. W.
Right arrow Articles by Wight, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, J. W.
Right arrow Articles by Wight, T. N.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2391.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions

Jens W. Fischer; Susie A. Steitz; Pamela Y. Johnson; Allen Burke; Frank Kolodgie; Renu Virmani; Cecilia Giachelli; Thomas N. Wight

From Molekulare Pharmakologie (J.W.F.), Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Germany; the Departments of Bioengineering and Pathology (S.A.S., C.G.), University of Washington, Seattle, Wash; The Hope Heart Program at the Benaroya Research Institute at Virginia Mason (P.Y.J., T.N.W.), Seattle, Wash; and the Department of Cardiovascular Pathology (A.B., F.K.,R.V.), Armed Forces Institute of Pathology, Washington, DC.

Correspondence to Thomas N. Wight, PhD, Hope Heart Program, Benaroya Research Institute at Virginia Mason, 1124 Columbia Street, Seattle, WA 98104-2046. E-mail twight{at}hopeheart.org

Objective— Ectopic calcification localized to the intima of atherosclerotic plaque is a risk marker for cardiovascular events and increases the risk of aortic dissection during angioplasty. A variety of extracellular matrix molecules such as collagen type 1, bone sialoprotein, and osteopontin are known to regulate the biomineralization of bone and ectopic vascular calcification. In the present study, it was investigated whether decorin, a small leucine-rich proteoglycan expressed in bone and atherosclerotic plaque, is involved in arterial calcification.

Methods and Results— Calcification was induced in cultured bovine aortic smooth muscle cell (BASMC) by the addition of ß-glycerophosphate or inorganic phosphate. Northern and Western analysis revealed that decorin expression was strongly upregulated in mineralizing BASMC. Furthermore, overexpression of decorin using a retroviral expression vector resulted in a 3- to 4-fold elevation of calcium deposited on the BASMC monolayer. Increased calcification in response to decorin could also be mimicked by adding exogenous decorin to the cultures. In addition, human coronary atherosclerotic lesions taken from sudden-death patients showed marked colocalization of calcium deposits with decorin.

Conclusions— Decorin induces calcification of arterial smooth muscle cell cultures and colocalizes to mineral deposition in human atherosclerotic plaque, suggesting that decorin functions as promoter of intimal calcification.

Calcification of atherosclerotic plaques is positively correlated with plaque burden and cardiovascular mortality. The present study demonstrates that decorin expression enhances calcification of arterial smooth muscle cells in vitro and that decorin colocalizes with calcium deposits in human atherosclerotic plaques, suggesting that decorin is a promoter of vascular calcification.


Key Words: small leucine rich proteoglycan • decorin • extracellular matrix • vascular calcification • atherosclerosis




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. Mathew, R. J. Lund, L. R. Chaudhary, T. Geurs, and K. A. Hruska
Vitamin D Receptor Activators Can Protect against Vascular Calcification
J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1509 - 1519.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. Hadfield, C. F. Rock, C. A. Inkson, S. L. Dallas, L. Sudre, G. A. Wallis, R. P. Boot-Handford, and A. E. Canfield
HtrA1 Inhibits Mineral Deposition by Osteoblasts: REQUIREMENT FOR THE PROTEASE AND PDZ DOMAINS
J. Biol. Chem., February 29, 2008; 283(9): 5928 - 5938.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. P. Burke, F. D. Kolodgie, and R. Virmani
Fetuin-A, Valve Calcification, and Diabetes: What Do We Understand?
Circulation, May 15, 2007; 115(19): 2464 - 2467.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Dugan, V. W.-C. Yang, D. J. McQuillan, and M. Hook
Decorin Modulates Fibrin Assembly and Structure
J. Biol. Chem., December 15, 2006; 281(50): 38208 - 38216.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Qin, M. A. Corriere, L. M. Matrisian, and R. J. Guzman
Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1510 - 1516.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. L. Higgins, S. A. Marvel, and J. D. Morrisett
Quantification of Calcification in Atherosclerotic Lesions
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1567 - 1576.
[Abstract] [Full Text] [PDF]